Discontinued Operations - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net income (loss) from discontinued operations	$ (257)	$ (898)	$ 27,119	$ (454)
Depreciation			762	1,369
Amortization of intangible assets	430	430	1,290	1,290
Non-cash lease expense			570	885
(Gain) loss on disposal of discontinued operations			(26,680)	0
Share-based compensation			284	322
Provision for bad debt			73	435
Deferred income taxes			(221)	225
Accounts receivable			5,525	1,466
Inventory			(246)	(4,539)
Other assets			607	(582)
Accounts payable			685	1,821
Accrued compensation			(784)	345
Discontinued Operations, Disposed of by Sale | Healthcare Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net income (loss) from discontinued operations	$ (257)	$ (898)	27,119	(454)
Depreciation			332	966
Amortization of intangible assets			0	1
Non-cash lease expense			273	606
Write-off of borrowing costs			16	30
(Gain) loss on disposal of discontinued operations			(26,680)	0
Share-based compensation			1	5
(Gain )Loss on disposal of assets			135	(253)
Provision for bad debt			17	30
Deferred income taxes			(176)	(672)
Accounts receivable			1,333	(385)
Inventory			(681)	(1,357)
Other assets			1,044	(95)
Accounts payable			994	1,387
Accrued compensation			(580)	4
Deferred revenue			(101)	26
Operating lease liabilities			(283)	18
Other liabilities			(1,730)	683
Net cash provided by (used in) operating activities			1,033	540
Net cash provided by (used in) investing activities			0	(345)
Net cash provided by (used in) financing activities			347	78
Net increase (decrease) in cash and cash equivalents and restricted cash			$ 1,380	$ 273